sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Announces Shareholdings in Avadel Pharmaceuticals
The Vanguard Group, Inc. has disclosed its interests in Avadel Pharmaceuticals plc, a company involved in a takeover bid. As per the Form 8.3 filing under the Irish Takeover Panel rules, Vanguard holds 5,563,133 ordinary shares, representing a 5.71% stake in Avadel Pharmaceuticals as of November 18, 2025. The disclosure also outlined recent transactions, with Vanguard purchasing additional shares at prices of 22.94 USD and 23.08 USD per share.
No cash-settled or stock-settled derivatives were declared. Additionally, Vanguard reported no indemnity, option agreements, or other relevant securities agreements connected to the dealings in Avadel. This positions Vanguard as a notable shareholder in Avadel, participating actively in the current takeover proceedings.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.